🤖Remedy Robotics Tests Telesurgery for Stroke Clot Removal Through Its N1 System
Surgeons may soon remove stroke clots from miles away
TL;DR
Remedy Robotics is testing whether surgeons can perform stroke thrombectomies remotely with its N1 System. Only about 1 in 10 eligible patients get the procedure today. Remote access could change that, but the infrastructure and proof aren't there yet.
Remedy Robotics is testing whether a surgeon can remove a stroke clot from miles away. Its N1 System is built for thrombectomies, the standard brain operation for acute ischemic strokes, and the company has already run remote tests. If you build medical software or robotics control systems, this one is worth a look. The N1 uses a steerable catheter that needs no guide wire, and a computer-vision algorithm tracks the tip's rotation inside the body. Surgeons steer by toggling on the X-ray image, and the system handles the rest. The numbers are the reason anyone cares. At least 5 million people suffer ischemic strokes each year, and stroke is the fourth leading cause of death in the US. Only about 1 in 10 eligible patients currently receive a thrombectomy. The system was tested on a small group of patients, so this is early. Telesurgery here depends on communications infrastructure, hospital workflows, and evidence that patients actually benefit.

Key Points
The N1 System's robotic arm advances a steerable catheter while tiny wires pull its tip in any direction, so no guide wire is needed to pave the path.
Keep reading — it's free
Enter your email to keep reading — plus the best of AI & tech, daily. Free, forever.
Already a member? Sign in
Comments
Be the first to comment